78 results on '"Alegre-Sancho, J. J."'
Search Results
2. POS0832 IMMUNOSUPPRESSION VERSUS COMBINATION OF IMMUNOSUPPRESSION AND ORAL GLUCOCORTICOIDS FOR SKIN FIBROSIS IN EARLY DIFFUSE SYSTEMIC SCLEROSIS PATIENTS. A TARGET TRIAL EMULATION STUDY FROM THE EUSTAR DATABASE
3. AB1233 ROLE OF HEMATOLOGICAL INDICES IN SYSTEMIC SCLEROSIS: USE AS A PREDICTOR OF SUBCLINICAL VASCULAR DAMAGE, CARDIOVASCULAR EVENTS AND DEATH
4. AB1000 ANIFROLUMAB IN SYSTEMIC LUPUS ERYTHEMATOSUS. SPANISH NATIONAL REGISTRY IN A REAL-WORLD SETTING
5. AB1354 SPANISH NATIONAL MULTICENTER REGISTRY OF PREGNANCY IN SYSTEMIC AUTOINMUNE RHEUMATIC DISEASES
6. AB1017 DETERMINANTS OF SLEEP DISORDERS IN AXIAL SPONDYLOARTHRITIS: A CONTROLLED STUDY
7. AB1275 NEISSERIA GONORRHOEAE ARTHRITIS: A GROWING PROBLEM
8. Pulse wave velocity and augmentation index are not independently associated with carotid atherosclerosis in patients with rheumatoid arthritis
9. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
10. POS0914 LATE SKIN FIBROSIS IN SYSTEMIC SCLEROSIS: A STUDY FROM THE EUSTAR COHORT
11. POS1276 HUMORAL IMMUNE RESPONSE TO SARS-COV-2 VACCINE IN RITUXIMAB-TREATED PATIENTS
12. OP0139 IMPACT OF CHRONIC JOINT DISEASES ON THE SEXUAL SPHERE WITH REGARDS TO A HEALTHY POPULATION: A MULTICENTER STUDY.
13. EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT
14. AB0806 THE JOURNEY OF AXIAL SPONDYLOARTHRITIS IN SPAIN: FROM THE GENERAL PRACTITIONER TO THE RHEUMATOLOGIST
15. POS0861 EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT
16. POS0168 BONE MINERAL DENSITY IN PATIENTS WITH MULTIPLE SCLEROSIS. A DESCRIPTIVE STUDY FROM A UNIQUE CENTER FROM THE EAST OF SPAIN
17. FRI0446 VIRAL ARTHRITIS: DESCRIPTIVE ANALYSIS OF A SERIES OF 131 PATIENTS
18. AB0593 DOES REALLY EXIST MIXED CONNECTIVE TISSUE DISEASE?
19. AB0594 EFFECTIVENESS OF RITUXIMAB IN CSDMARDS-RESISTANT ACTIVE MIXED CONNECTIVE TISSUE DISEASE
20. AB0806 DOES VITAMIN D INFLUENCE THE ACTIVITY OF THE DISEASE IN PATIENTS WITH PSORIATIC ARTHRITIS?
21. AB0711 USEFULNESS OF THE TRABECULAR BONE SCORE AS A PREDICTOR OF VERTEBRAL FRACTURE IN PATIENTS WITH AXIAL SPONDYLOARTHROPATHY
22. AB0595 EFFECTIVENESS OF TOPICAL SODIUM TIOSULFATE FOR THE TREATMENT OF CALCINOSIS-ASSOCIATED CUTANEOUS ULCERS IN PATIENTS WITH SYSTEMIC SCLEROSIS
23. THU0307 RESPONSE OF BEHÇET’S REFRACTORY ORAL AND/OR GENITAL ULCERS TO APREMILAST IN COMBINATION VS MONOTHERAPY. NATIONAL MULTICENTER STUDY OF 51 CASES OF CLINICAL PRACTICE
24. AB0620 EFFECTIVENESS OF RITUXIMAB IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS. A MULTICENTER ANALYSIS.
25. AB0807 VITAMIN D ROLE IN VASCULAR DAMAGE PROGRESSION IN PATIENTS WITH PSORIATIC ARTHRITIS
26. AB0163 ANTI-KU ANTIBODIES: MUCH MORE THAN SCLEROMYOSITIS
27. FRI0377 BARIATRIC SURGERY: EFFECTS ON BONE METABOLISM
28. Update of EULAR recommendations for the treatment of systemic sclerosis
29. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
30. FRI0696 Patient activation and adherence to biological therapy: preliminary results
31. DRUG PERSISTENCE OF JAK INHIBITORS COMPARED TO BIOLOGIC DRUGS IN REAL-WORLD PRACTICE IN PATIENTS WITH RHEUMATOID ARTHRITIS.
32. RITUXIMAB IN SYSTEMIC SCLEROSIS : SAFETY AND EFFICACY DATA FROM THE EUSTAR NETWORK
33. Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis. a 10-year longitudinal study from the EUSTAR database
34. NEISSERIA GONORRHOEAE ARTHRITIS: A GROWING PROBLEM.
35. DETERMINANTS OF SLEEP DISORDERS IN AXIAL SPONDYLOARTHRITIS: A CONTROLLED STUDY.
36. Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis
37. AB0221 Correlation between rheumatoid arthritis and periodontal disease
38. FRI0378 Interleukin 6 and vascular disease in patients with systemic sclerosis
39. Bosentan therapy for cutaneous fibrosis in systemic sclerosis
40. Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy
41. Cauda equina tumour presenting as atypical sciatica
42. Subarachnoid Haemorrhage Secondary to Ruptured Cerebral Aneurysm in a Patient with Osteogenesis Imperfecta
43. Terapias hormonales, fertilidad y embarazo en el síndrome antifosfolipídico.
44. Is there a role for TNF-alpha antagonists in the treatment of SSc? EUSTAR expert consensus development using the Delphi technique
45. Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
46. Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus
47. LILRA3 deficiency is not involved in the giant cell arteritis and systemic sclerosis predisposition
48. Pelvic arteriovenous malformation as a rare cause of sciatica.
49. Cauda equina tumour presenting as atypical sciatica.
50. Subarachnoid Haemorrhage Secondary to Ruptured Cerebral Aneurysm in a Patient with Osteogenesis Imperfecta.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.